Molecular mechanism of thiazolidinedione-mediated inhibitory effects on osteoclastogenesis.

Molecular mechanism of thiazolidinedione-mediated inhibitory effects on osteoclastogenesis.

Thiazolidinediones are synthetic peroxisome proliferator-activated receptor γ agonists used to treat type 2 diabetes mellitus. Clinical evidence indicates that thiazolidinediones increase fracture risks in type 2 diabetes mellitus patients, but the mechanism by which thiazolidinediones augment fract...

Full description

Bibliographic Details
Main Authors:	Dongfeng Zhao, Zhenqi Shi, Amy H Warriner, Ping Qiao, Huixian Hong, Yongjun Wang, Xu Feng
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25032991/?tool=EBI

Similar Items

Retraction: Molecular Mechanism of Thiazolidinedione-Mediated Inhibitory Effects on Osteoclastogenesis.
by: PLOS ONE Editors
Published: (2020-01-01)

Inhibitory activity on RANKL-mediated osteoclastogenesis of Glossogyne tenuifolia extract
by: Shih-Wei Wang, et al.
Published: (2014-01-01)

Thiazolidinedione-Induced Fluid Retention: Recent Insights into the Molecular Mechanisms
by: Jerzy Bełtowski, et al.
Published: (2013-01-01)

Oleanolic acid exerts bone protective effects in ovariectomized mice by inhibiting osteoclastogenesis
by: Dongfeng Zhao, et al.
Published: (2018-05-01)

Challenges in drug discovery for thiazolidinedione substitute
by: Jian-ping Ye
Published: (2011-10-01)

Inhibitory effects of ChondroT and its constituent herbs on RANKL-induced osteoclastogenesis
by: Rui Hong Guo, et al.
Published: (2019-11-01)

Immunological Studies on the Physiopathological Functions of Osteoclastogenesis Inhibitory Factor(OCIF)
by: Yano, Kazuki
Published: (2011)

Chemotherapy and Chemoprevention by Thiazolidinediones
by: Eleonore Fröhlich, et al.
Published: (2015-01-01)

Niclosamide and its derivative DK‐520 inhibit RANKL‐induced osteoclastogenesis
by: Yurui Jiao, et al.
Published: (2020-08-01)

Thiazolidinediones and Edema: Recent Advances in the Pathogenesis of Thiazolidinediones-Induced Renal Sodium Retention
by: Shoko Horita, et al.
Published: (2015-01-01)

A new series of 2,4-thiazolidinediones endowed with potent aldose reductase inhibitory activity
by: Sever Belgin, et al.
Published: (2021-03-01)

IL-11 produced by breast cancer cells augments osteoclastogenesis by sustaining the pool of osteoclast progenitor cells
by: McCoy Erin M, et al.
Published: (2013-01-01)

Editorial: Special Issue on “Molecular Mechanisms Regulating Osteoclastogenesis”
by: Giacomina Brunetti, et al.
Published: (2020-10-01)

Molecular regulatory mechanisms of osteoclastogenesis through cytoprotective enzymes
by: Hiroyuki Kanzaki, et al.
Published: (2016-08-01)

Intrinsic Restriction of TNF-Mediated Inflammatory Osteoclastogenesis and Bone Resorption
by: Baohong Zhao, et al.
Published: (2020-10-01)

Inhibitory Effect of <i>Asplenium incisum</i> on Bacterial Growth, Inflammation, and Osteoclastogenesis
by: Seong-Hee Moon, et al.
Published: (2021-06-01)

Inhibitory Effect of Chlorpromazine on RANKL-Induced Osteoclastogenesis in Mouse Bone Marrow Cells
by: Hiroharu Kawamura, et al.
Published: (2011-01-01)

The Inhibitory Effect of Alisol A 24-Acetate from Alisma canaliculatum on Osteoclastogenesis
by: Kwang-Jin Kim, et al.
Published: (2015-01-01)

NF-κB-Mediated Regulation of Osteoclastogenesis
by: Brendan F. Boyce, et al.
Published: (2015-03-01)

Fc gamma receptor mediated modulation of osteoclastogenesis
by: Doonan, James Joseph
Published: (2014)

Renal and Vascular Mechanisms of Thiazolidinedione-Induced Fluid Retention
by: Tianxin Yang, et al.
Published: (2008-01-01)

Therapeutic Actions of the Thiazolidinediones in Alzheimer’s Disease
by: María José Pérez, et al.
Published: (2015-01-01)

Thiazolidinedione induced thyroid associated orbitopathy
by: McCann John D, et al.
Published: (2007-04-01)

The systemic bone protective effects of Gushukang granules in ovariectomized mice by inhibiting osteoclastogenesis and stimulating osteoblastogenesis
by: Qiang Wang, et al.
Published: (2018-03-01)

Mepazine Inhibits RANK-Induced Osteoclastogenesis Independent of Its MALT1 Inhibitory Function
by: Laura Meloni, et al.
Published: (2018-11-01)

The effect of metformin and thiazolidinedione use on lung cancer in diabetics
by: Mazzone Peter J, et al.
Published: (2012-09-01)

Inhibitory Effect of KP-A038 on Osteoclastogenesis and Inflammatory Bone Loss Is Associated With Downregulation of Blimp1
by: Hye Jung Ihn, et al.
Published: (2019-04-01)

Biological potential of thiazolidinedione derivatives of synthetic origin
by: Sucheta, et al.
Published: (2017-12-01)

Effects of Thiazolidinedione and New Antidiabetic Agents on Stroke
by: Chang Ho Ahn, et al.
Published: (2019-05-01)

Factors associated with results and conclusions of trials of thiazolidinediones.
by: Gail Rattinger, et al.
Published: (2009-06-01)

Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS)
by: Pascal Froment, et al.
Published: (2006-01-01)

Thiazolidinediones on PPARγ: The Roles in Bone Remodeling
by: Wei Wei, et al.
Published: (2011-01-01)

Inhibitory effects of low intensity pulsed ultrasound on osteoclastogenesis induced in vitro by breast cancer cells
by: Valeria Carina, et al.
Published: (2018-08-01)

Neuroprotective Effect and Mechanism of Thiazolidinedione on Dopaminergic Neurons In Vivo and In Vitro in Parkinson’s Disease
by: Yanqin Wang, et al.
Published: (2017-01-01)

Trem2 mediated Syk-dependent ROS amplification is essential for osteoclastogenesis in periodontitis microenvironment
by: Yuteng Weng, et al.
Published: (2021-04-01)

Osteoblast–Osteoclast Coculture Amplifies Inhibitory Effects of FG‐4592 on Human Osteoclastogenesis and Reduces Bone Resorption
by: Philippa A Hulley, et al.
Published: (2020-07-01)

Studies on the Synthesis of Pyrazolyl-thiazolidinedione Derivatives as Antibacterial Agents
by: Chong Hou, et al.
Published: (2014)

Thiazolidinedione and cardiovascular risk in type 2 diabetes mellitus
by: Yenny Yenny
Published: (2016-04-01)

Thiazolidinediones are associated with a reduced risk of COPD exacerbations
by: Rinne ST, et al.
Published: (2015-08-01)

Redefining the role of thiazolidinediones in the management of type 2 diabetes
by: Anthony H Barnett
Published: (2009-01-01)